2011
DOI: 10.1186/1475-2875-10-336
|View full text |Cite
|
Sign up to set email alerts
|

Vivax malaria in Mauritania includes infection of a Duffy-negative individual

Abstract: BackgroundDuffy blood group polymorphisms are important in areas where Plasmodium vivax is present because this surface antigen is thought to act as a key receptor for this parasite. In the present study, Duffy blood group genotyping was performed in febrile uninfected and P. vivax-infected patients living in the city of Nouakchott, Mauritania.MethodsPlasmodium vivax was identified by real-time PCR. The Duffy blood group genotypes were determined by standard PCR followed by sequencing of the promoter region an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
92
1
3

Year Published

2012
2012
2017
2017

Publication Types

Select...
7
1
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 99 publications
(103 citation statements)
references
References 60 publications
7
92
1
3
Order By: Relevance
“…Malaria has also been found in Angola and Equatorial Guinea in Duffy negative individuals [24]. P. vivax malaria has also been detected in Duffy antigen negative individuals in Mauritania [25]. Similar infections have been reported in Brazil [26] and Kenya [23].…”
Section: Discussionsupporting
confidence: 52%
“…Malaria has also been found in Angola and Equatorial Guinea in Duffy negative individuals [24]. P. vivax malaria has also been detected in Duffy antigen negative individuals in Mauritania [25]. Similar infections have been reported in Brazil [26] and Kenya [23].…”
Section: Discussionsupporting
confidence: 52%
“…This was because of the assumption that Duffy negative individuals, found in high frequencies on the continent (Howes et al, 2011), are refractory to P. vivax infection. This supposition was incorporated into the model, despite observations of P. vivax malaria infections in Duffy-negative individuals in Madagascar ( Menard et al, 2010) and on the mainland of the continent (Ryan et al, 2006;Mendes et al, 2011;Wurtz et al, 2011). While this information contradicts our working assumption of complete protection, there is insufficient evidence to determine if these are more than just rare occurrences on the continent that would have a significant effect on the epidemiology of P. vivax in Africa.…”
Section: Africa+mentioning
confidence: 73%
“…Recently, Duffy-null individuals were found to be infected with P. vivax, both throughout Africa (Kenya, Madagascar, Mauritania, Cameroon, Angola, Equatorial Guinea, Ethiopia, and Sudan) and in South America (12)(13)(14)(15)(16)(17)(18)(19)(20)(21), raising the question: How can P. vivax invade in the absence of Duffy blood group expression? Is it possible that mutations in the cysteine-rich region 2 of the P. vivax DBP1 allows binding to another protein on the surface of Duffy-null erythrocytes, unrelated to the Duffy?…”
Section: Dna Expansionmentioning
confidence: 99%